Please login to the form below
Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more
E-cigarettes can save lives - Teva gains approval for EpiPen generic
Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland
The latest from pharma, biotech and healthcare
AI company Sensyne raises £60m in IPO
University of Oxford-developed tech powers health-focused company
Love Island ads fuel body image problems, warn health leaders
Calls for watchdog to regulate cosmetic surgery adverts
‘Common Rulebook’ Brexit plans include medicines – but face backlash
Government compromises could be opposed from both sides
Daily Brief: Brexit reshuffle brings new health minister, Celgene thalassemia success, Wellcome ready to leap into future
A round-up from pharma, biotech and healthcare
Vertex calls NHS England ‘outrageous’ as Orkambi talks stall again
Public row about confidential pricing talks drags on
The NHS at 70: celebrations, renewed reforms and difficult choices
Health service remains popular with public, but faces daunting need for radical change
Eminent surgeon Atul Gawande to lead Amazon’s health venture
Surgeon, public health doctor and 'big thinker' on healthcare to lead new venture
The shifting healthcare landscape
-
The power of pharma businesses to drive social changeThe importance of CSR programmes
-
The state of trustRoche’s Future-proofing Healthcare event shows how the current model is a complicated one
-
NHS could save £7bn with greater diagnostics useReport suggests IVD tests could be key to big savings
-
Chiesi targets patient adherence via mobile appInitiative will see asthma and COPD patients receive device training support
-
May earmarks £20bn for the NHS - but experts say it's not enoughBut claims of a “Brexit dividend” are rubbished
-
Another IO knockback as Tecentriq combo fails phase III trialThe bulk of CRC patients with MSS currently look set to be excluded from cancer immunotherapy
-
Daily BriefA rapid round-up of the top pharma, biotech and healthcare news
-
Daily Brief: Deal done, Takeda to cut $1.4bn, Brexit latest, Valeant rebrandsA rapid round-up of the top pharma, biotech and healthcare news
-
Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and moreA rapid round-up of pharma, biotech and healthcare news
-
Paris biocluster appoints Stéphane Roques as new chiefFormer general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment
-
Picker appoints new CEOChris Graham to focus on person-centred care
-
EFPIA appoints new director generalNathalie Moll takes up the role from April
-
IFPMA appoints director generalThomas Cueni brings expertise from Interpharma and EFPIA
-
CureVac’s CEO appointed to EC High Level Group
Dr Ingmar Hoerr will advise on Horizon 2020 and future innovation programmes
Latest healthcare appointments
Featured jobs
- Account Director or Senior Account Director
-
Salary TBC
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
starting from £32, 500
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
-
Medical Director
-
Excellent benefits
-
Market Access Consultant - Cheshire
-
Negotiable
-
Senior Medical Writer
-
Great salary and bebefits
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Scientific Director
-
Great salary and bebefits
- Freelance Senior Account Manager – healthcare advertising
-
Employment Type:. Healthcare Advertising Jobs. Salary:. 250 to 320 per day
-
Senior Medical Writer
-
Great salary and benefits
Subscribe to our email news alerts
- Novo’s oral diabetes drug hits the mark again
- AZ’s soon-to-be lung cancer blockbuster Tagrisso approved in Japan
- Envision Pharma Group relocates to support growth
- Evoke Group unveils new identity
- Roche’s Alecensa backed by China’s National Drug Administration
- FDA green lights BMS’ Opdivo for ‘hard-to-treat’ small cell lung cancer
PMHub
Hanson Zandi
Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...
Latest intelligence
- The European Medicines Agency: PRIME’d for access?
- Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
- How can pharma engage with key stakeholders on NHS service transformation?
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
- The race for an HIV ‘cure’
- Supercharging therapies as pharma and patients work together...
Quick links
Infographics
